TY - JOUR
T1 - A 3-week ketogenic diet increases skeletal muscle insulin sensitivity in individuals with obesity
T2 - a randomized, controlled crossover trial
AU - Luong, Thien Vinh
AU - Pedersen, Mette Glavind Bülow
AU - Abild, Caroline Bruun
AU - Lauritsen, Katrine Meyer
AU - Kjærulff, Mette Louise Gram
AU - Møller, Niels
AU - Gormsen, Lars Christian
AU - Søndergaard, Esben
N1 - © 2024 by the American Diabetes Association.
PY - 2024/10
Y1 - 2024/10
N2 - A ketogenic diet (KD) can induce weight loss and improve glycemic regulation, potentially reducing the risk of type 2 diabetes development. To elucidate the underlying mechanisms behind these beneficial effects of a KD, we investigated the impact of a KD on organ-specific insulin sensitivity (IS) in skeletal muscle, liver, and adipose tissue. We hypothesized that a KD would increase IS in skeletal muscle. The study included 11 individuals with obesity who underwent a randomized, crossover trial with two 3-week interventions: 1) a KD and 2) a standard diet. Skeletal muscle IS was quantified as the increase in glucose disposal during a hyperinsulinemic-euglycemic clamp (HEC). Hepatic IS and adipose tissue IS were quantified as the relative suppression of endogenous glucose production (EGP) and the relative suppression of palmitate flux during the HEC. The KD led to a 2.2-kg weight loss and increased insulin-stimulated glucose disposal, whereas the relative suppression of EGP during the HEC was similar. In addition, the KD decreased insulin-mediated suppression of lipolysis. In conclusion, a KD increased skeletal muscle IS in individuals with obesity.
AB - A ketogenic diet (KD) can induce weight loss and improve glycemic regulation, potentially reducing the risk of type 2 diabetes development. To elucidate the underlying mechanisms behind these beneficial effects of a KD, we investigated the impact of a KD on organ-specific insulin sensitivity (IS) in skeletal muscle, liver, and adipose tissue. We hypothesized that a KD would increase IS in skeletal muscle. The study included 11 individuals with obesity who underwent a randomized, crossover trial with two 3-week interventions: 1) a KD and 2) a standard diet. Skeletal muscle IS was quantified as the increase in glucose disposal during a hyperinsulinemic-euglycemic clamp (HEC). Hepatic IS and adipose tissue IS were quantified as the relative suppression of endogenous glucose production (EGP) and the relative suppression of palmitate flux during the HEC. The KD led to a 2.2-kg weight loss and increased insulin-stimulated glucose disposal, whereas the relative suppression of EGP during the HEC was similar. In addition, the KD decreased insulin-mediated suppression of lipolysis. In conclusion, a KD increased skeletal muscle IS in individuals with obesity.
UR - http://www.scopus.com/inward/record.url?scp=85204744590&partnerID=8YFLogxK
U2 - 10.2337/db24-0162
DO - 10.2337/db24-0162
M3 - Journal article
C2 - 39052652
SN - 0012-1797
VL - 73
SP - 1631
EP - 1640
JO - Diabetes
JF - Diabetes
IS - 10
ER -